Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 7:9:648939.
doi: 10.3389/fped.2021.648939. eCollection 2021.

Current Status of Newborn Screening in Southeastern Europe

Affiliations

Current Status of Newborn Screening in Southeastern Europe

Vanesa Koracin et al. Front Pediatr. .

Abstract

Significant part of Southeastern Europe (with a population of 76 million) has newborn screening (NBS) programs non-harmonized with developed European countries. Initial survey was conducted in 2013/2014 among 11 countries from the region (Albania, Bulgaria, Bosnia and Herzegovina (BIH), Croatia, Kosovo, Macedonia, Moldova, Montenegro, Romania, Serbia, and Slovenia) to assess the main characteristics of their NBS programs and their future plans. Their cumulative population at that time was ~52,5 million. At that time, none of the countries had an expanded NBS program, while phenylketonuria screening was not introduced in four and congenital hypothyroidism in three of 11 countries. We repeated the survey in 2020 inviting the same 11 countries, adding Cyprus, Greece, Hungary, and Malta (due to their geographical position in the wider region). The aims were to assess the current state, to evaluate the change in the period, and to identify the main obstacles impacting the implementation of expanded NBS and/or reaching a wider population. Responses were collected from 12 countries (BIH-Federation of BIH, BIH-Republic of Srpska, Bulgaria, Croatia, Greece, Hungary, Kosovo, North Macedonia, Malta, Montenegro, Romania, Serbia, Slovenia) with a population of 68.5 million. The results of the survey showed that the regional situation regarding NBS only modestly improved in this period. All of the surveyed countries except Kosovo screened for at least congenital hypothyroidism, while phenylketonuria was not screened in four of 12 countries. Croatia and Slovenia implemented an expanded NBS program using tandem mass spectrometry from the time of last survey. In conclusion, the current status of NBS programs in Southeastern Europe is very variable and is still underdeveloped (or even non-existent) in some of the countries. We suggest establishing an international task-force to assist with implementation and harmonization of basic NBS services where needed.

Keywords: NBS; dried blood sample; expanded NBS program; neonatal screening; newborn screening; southeastern Europe; survey.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The map of southeastern Europe with countries represented in the survey (in blue) and their populations.

References

    1. CDC Grand Rounds: Newborn screening and improved outcomes . Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. (2012) 61:390–3. - PubMed
    1. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. (1963) 32:338–43. - PubMed
    1. Therrell BL, David Padilla C, Loeber JG, Kneisser I, Saadallah A, Borrajo GJC, et al. . Current status of newborn screening worldwide: 2015. Semin Perinatol. (2015) 39:171–87. 10.1053/j.semperi.2015.03.002 - DOI - PubMed
    1. Chace DH. Mass spectrometry in newborn and metabolic screening: historical perspective and future directions. J Mass Spectrom. (2009) 44:163–70. 10.1002/jms.1528 - DOI - PubMed
    1. Smon A, Repic Lampret B, Groselj U, Zerjav Tansek M, Kovac J, Perko D, et al. . Next generation sequencing as a follow-up test in an expanded newborn screening programme. Clin Biochem. (2018) 52:48–55. 10.1016/j.clinbiochem.2017.10.016 - DOI - PubMed